Caterpillar stock drops nearly 3% as tariff jitters rattle industrials — what to watch next
21 January 2026
1 min read

Caterpillar stock drops nearly 3% as tariff jitters rattle industrials — what to watch next

New York, Jan 20, 2026, 20:45 (EST) — Market closed

  • Caterpillar dropped close to 3% in the most recent session, underperforming the wider market decline.
  • Threats of tariffs linked to Greenland drove up volatility and weighed on cyclical stocks.
  • A new analyst price-target boost kept CAT in focus ahead of its upcoming update.

Caterpillar Inc shares closed Tuesday down 2.8% at $629, having fluctuated between $625.07 and $644.00 during the session. Trading volume hit roughly 2.7 million shares.

The decline followed Wall Street’s sharpest single-day fall in three months, triggered by President Donald Trump’s threat to impose new tariffs on imports from eight European nations amid talks to buy Greenland. “I’m not at the point yet” where this situation “is going to precipitate a correction,” said Jamie Cox, managing partner at Harris Financial Group. 1

For Caterpillar, the tape is crucial since it directly reflects major spending on construction, mining, and energy projects—areas that often get postponed when businesses grow cautious. Even just talk of tariffs can spark worries about rising supply chain costs and weaker demand abroad.

The stock lagged behind several machinery rivals today. Deere & Co dropped 1.11%, and Toro Co dipped 1.83%. Caterpillar slid as well, now trading roughly 4% below its 52-week peak reached on Jan. 16, per MarketWatch data. 2

Analysts kept the buzz alive despite the market’s dip. Oppenheimer bumped up its price target on Caterpillar, lifting it to $700 from $645 while maintaining an Outperform rating. They cited changing macro cross-currents heading into the fourth-quarter earnings period. 3

Dividend mechanics might have nudged the move slightly. Caterpillar shares went ex-dividend Tuesday, so anyone buying now won’t get the upcoming payout. The $1.51 quarterly dividend is set for Feb. 19. 4

The bigger risk this week? Policy whiplash. If tariff threats turn into actual measures—or if the list grows—industrial stocks like Caterpillar could take a double hit: rising input costs and weaker demand as customers delay equipment purchases.

Caterpillar’s fourth-quarter and full-year results drop before the bell Thursday, Jan. 29. The company has its webcast and analyst call set for 7:30 a.m. CST. 5

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Merck (MRK) stock ends higher on long-term Keytruda cancer-vaccine data; Guardant pact and earnings ahead
Previous Story

Merck (MRK) stock ends higher on long-term Keytruda cancer-vaccine data; Guardant pact and earnings ahead

Marvell (MRVL) stock slides with tech as Trump tariff threat jolts Wall Street — what to watch next
Next Story

Marvell (MRVL) stock slides with tech as Trump tariff threat jolts Wall Street — what to watch next

Go toTop